| Results summary | View all lists in GO:BiolProc | View all genes in G03CA.profile.ud50 |
regulation of biological process Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule. enrichment: 1.51-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 217729_S_AT | AES | D | R | S | amino-terminal enhancer of split | ||||||||
| 212025_S_AT | FLII | D | R | flightless I homolog (Drosophila) | |||||||||
| 207069_S_AT | SMAD6 | R | SMAD family member 6 | ||||||||||
| 219255_X_AT | IL17RB | interleukin 17 receptor B | |||||||||||
| 204285_S_AT | PMAIP1 | G | S | phorbol-12-myristate-13-acetate-induced protein 1 | |||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 204316_AT | RGS10 | S | regulator of G-protein signalling 10 | ||||||||||
| 213260_AT | FOXC1 | D | E | R | S | forkhead box C1 | |||||||
| 200889_S_AT | SSR1 | G | T | signal sequence receptor, alpha (translocon-associated protein alpha) | |||||||||
| 218192_AT | IHPK2 | G | inositol hexaphosphate kinase 2 | ||||||||||
| 205809_S_AT | WASL | P | R | Wiskott-Aldrich syndrome-like | |||||||||
| 212345_S_AT | CREB3L2 | R | cAMP responsive element binding protein 3-like 2 | ||||||||||
| 207678_S_AT | SOX30 | R | SRY (sex determining region Y)-box 30 | ||||||||||
| 209723_AT | SERPINB9 | G | S | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | |||||||||
| 203556_AT | ZHX2 | R | zinc fingers and homeoboxes 2 | ||||||||||
| 207239_S_AT | PCTK1 | P | PCTAIRE protein kinase 1 | ||||||||||
| 202023_AT | EFNA1 | D | C | S | ephrin-A1 | ||||||||
| 213746_S_AT | FLNA | T | D | R | S | filamin A, alpha (actin binding protein 280) | |||||||
| 205287_S_AT | TFAP2C | R | C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | |||||||||
| 208793_X_AT | SMARCA4 | R | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | ||||||||||
| 204159_AT | CDKN2C | G | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | ||||||||||
| 219388_AT | GRHL2 | R | grainyhead-like 2 (Drosophila) | ||||||||||
| 219551_AT | EAF2 | G | R | ELL associated factor 2 | |||||||||
| 221890_AT | ZNF335 | R | zinc finger protein 335 | ||||||||||
| 209431_S_AT | PATZ1 | R | POZ (BTB) and AT hook containing zinc finger 1 | ||||||||||
| 218205_S_AT | MKNK2 | P | S | MAP kinase interacting serine/threonine kinase 2 | |||||||||
| 209650_S_AT | TBC1D22A | S | TBC1 domain family, member 22A | ||||||||||
| 211936_AT | HSPA5 | G | X | S | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | ||||||||
| 205842_S_AT | JAK2 | D | P | S | Janus kinase 2 (a protein tyrosine kinase) | ||||||||
| 41160_AT | MBD3 | P | R | methyl-CpG binding domain protein 3 | |||||||||
| 202871_AT | TRAF4 | G | D | S | TNF receptor-associated factor 4 | ||||||||
| 201236_S_AT | BTG2 | G | D | X | P | R | BTG family, member 2 | ||||||
| 209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 202621_AT | IRF3 | P | R | interferon regulatory factor 3 | |||||||||
| 217272_S_AT | SERPINB13 | P | serpin peptidase inhibitor, clade B (ovalbumin), member 13 | ||||||||||
| 209675_S_AT | HNRPUL1 | R | heterogeneous nuclear ribonucleoprotein U-like 1 | ||||||||||
| 208216_AT | DLX4 | D | R | distal-less homeobox 4 | |||||||||
| 203312_X_AT | ARF6 | T | P | C | S | ADP-ribosylation factor 6 | |||||||
| 208937_S_AT | ID1 | D | R | S | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||||
| 220038_AT | SGK3 | G | X | P | serum/glucocorticoid regulated kinase family, member 3 | ||||||||
| 218412_S_AT | GTF2IRD1 | D | R | GTF2I repeat domain containing 1 | |||||||||
| 201321_S_AT | SMARCC2 | R | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | ||||||||||